期刊
BIOMEDICAL CHROMATOGRAPHY
卷 30, 期 6, 页码 818-828出版社
WILEY
DOI: 10.1002/bmc.3613
关键词
analytical quality by design; risk estimation matrix; extraction; robustness; stability
类别
资金
- University Grants Commission, New Delhi, India
The present studies describe the systematic quality by design (QbD)-oriented development and validation of a simple, rapid, sensitive and cost-effective reversed-phase HPLC bioanalytical method for nevirapine in rat plasma. Chromatographic separation was carried out on a C-18 column using isocratic 68:9:23% v/v elution of methanol, acetonitrile and water (pH3, adjusted by orthophosphoric acid) at a flow rate of 1.0mL/min using UV detection at 230nm. A Box-Behnken design was applied for chromatographic method optimization taking mobile phase ratio, pH and flow rate as the critical method parameters (CMPs) from screening studies. Peak area, retention time, theoretical plates and peak tailing were measured as the critical analytical attributes (CAAs). Further, the bioanalytical liquid-liquid extraction process was optimized using an optimal design by selecting extraction time, centrifugation speed and temperature as the CMPs for percentage recovery of nevirapine as the CAA. The search for an optimum chromatographic solution was conducted through numerical desirability function. Validation studies performed as per the US Food and Drug Administration requirements revealed results within the acceptance limit. In a nutshell, the studies successfully demonstrate the utility of analytical QbD approach for the rational development of a bioanalytical method with enhanced chromatographic separation and recovery of nevirapine in rat plasma. Copyright (C) 2015 John Wiley & Sons, Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据